Home - Products - Others - Other Targets - (3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol

(3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol

CAS No. 87095-75-8

(3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol( —— )

Catalog No. M31957 CAS No. 87095-75-8

(3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol has anti-oomycete potential.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 558 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    (3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol
  • Note
    Research use only, not for human use.
  • Brief Description
    (3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol has anti-oomycete potential.
  • Description
    (3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol has anti-oomycete potential.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    87095-75-8
  • Formula Weight
    282.4
  • Molecular Formula
    C19H22O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Glutaminase C-IN-1

    Glutaminase C-IN-1 is a Glutaminase C allosteric inhibitor.

  • pep2-SVKI

    Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and protein interacting with C kinase (PICK1). Increases amplitude of AMPA receptor-mediated currents and blocks long-term depression (LTD).

  • Lucidumol A

    Lucidumol A has relatively good effect against aldose reductase with IC50 of 19.1uM. Lucidumol A has cytotoxic activity, it reduced cell growth in three human carcinoma cells (Caco-2, HepG2, and HeLa cells) dose dependently with LC50s from 20.87 to 84.36 uM.